Guggenheim Maintains Buy on Vigil Neuroscience, Lowers Price Target to $16
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Yatin Suneja maintains a Buy rating on Vigil Neuroscience (NASDAQ:VIGL) but lowers the price target from $17 to $16.
August 14, 2024 | 5:24 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Guggenheim analyst Yatin Suneja maintains a Buy rating on Vigil Neuroscience but lowers the price target from $17 to $16.
The Buy rating suggests continued confidence in the stock, but the lowered price target indicates a slightly less optimistic outlook. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100